3,4-Dihydroxystyrene
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
4-vinylbenzene-1,2-diol
|
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 6053-02-7 |
| ATC code | none |
| PubChem | CID 151398 |
| ChemSpider | 133430 |
| KEGG | C06224 |
| Chemical data | |
| Formula | C8H8O2 |
| Molar mass | 136.15 g/mol |
|
|
|
|
| |
3,4-Dihydroxystyrene (DHS) is a centrally-acting inhibitor of the enzyme phenylalanine hydroxylase (PH).[1] It is likely that DHS and other PH inhibitors will never have clinical applications on account of their capacity for inducing hyperphenylalaninemia and phenylketonuria.
See also[edit]
References[edit]
- ^ Koizumi S, Matsushima Y, Nagatsu T, Iinuma H, Takeuchi T, Umezawa H (September 1984). "3,4-dihydroxystyrene, a novel microbial inhibitor for phenylalanine hydroxylase and other pteridine-dependent monooxygenases". Biochimica et Biophysica Acta 789 (2): 111–8. doi:10.1016/0167-4838(84)90194-8. PMID 6148105.
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

